My Quote Request
No products added yet
6505-01-243-5901
20 Products
NDC59930-1503-02
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
NDC59930-1503-02
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
MFG
WARRICK PHARMACEUTICALS INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.640 BETAMETHASONE DIPROPIONATE MILLIGRAMS AND 10.000 CLOTRIMAZOLE MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM USP 45GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
Related Searches:
NDC00168-0258-46
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
NDC00168-0258-46
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
MFG
NYCOMED US INC. DIV FOUGERA/SAVAGE LABS/PHARMADERM USE CAGE CODE 60910 FOR CATALOGING.
Description
ACTIVE INGREDIENT AND STRENGTH: 0.640 BETAMETHASONE DIPROPIONATE MILLIGRAMS AND 10.000 CLOTRIMAZOLE MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM USP 45GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
Related Searches:
NDC00472-0379-45
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
NDC00472-0379-45
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
MFG
ALPHARMA US PHARMACEUTICALS DIVISION DBA ALPHARMA
Description
ACTIVE INGREDIENT AND STRENGTH: 0.640 BETAMETHASONE DIPROPIONATE MILLIGRAMS AND 10.000 CLOTRIMAZOLE MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM USP 45GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
Related Searches:
NDC51672-4048-06
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
NDC51672-4048-06
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM,USP
NSN, MFG P/N
6505012435901
NSN
6505-01-243-5901
MFG
TARO PHARMACEUTICALS USA INC
Description
ACTIVE INGREDIENT AND STRENGTH: 0.640 BETAMETHASONE DIPROPIONATE MILLIGRAMS AND 10.000 CLOTRIMAZOLE MILLIGRAMS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE CREAM USP 45GM TUBE
PRIMARY CONTAINER CONTENT QUANTITY: 45.000 GRAMS
PRIMARY CONTAINER TYPE: TUBE
PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
SPECIAL FEATURES: FOR DERMATOLOGIC USE ONLY
Related Searches:
HYPAQUE SODIUM
DIATRIZOATE SODIUM FOR ORAL SOLUTION
NSN, MFG P/N
6505012437912
NSN
6505-01-243-7912
HYPAQUE SODIUM
DIATRIZOATE SODIUM FOR ORAL SOLUTION
NSN, MFG P/N
6505012437912
NSN
6505-01-243-7912
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS DIATRIZOATE SODIUM ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,WINTHROP PHARMACEUTICAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 59.87% IODINE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00024-0769-10
DIATRIZOATE SODIUM FOR ORAL SOLUTION
NSN, MFG P/N
6505012437912
NSN
6505-01-243-7912
NDC00024-0769-10
DIATRIZOATE SODIUM FOR ORAL SOLUTION
NSN, MFG P/N
6505012437912
NSN
6505-01-243-7912
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 GRAMS DIATRIZOATE SODIUM ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,WINTHROP PHARMACEUTICAL
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 59.87% IODINE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
INSULATARD NPH HUMAN
INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505012437919
NSN
6505-01-243-7919
INSULATARD NPH HUMAN
INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505012437919
NSN
6505-01-243-7919
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN, ISOPHANE PER MILLILITER
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORK PANCREAS
SPECIAL FEATURES: DERIVED BY ENZYMATIC MODIFICATION OF PORK INSULIN
Related Searches:
NDC50445-0222-01
INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505012437919
NSN
6505-01-243-7919
NDC50445-0222-01
INSULIN HUMAN ISOPHANE SUSPENSION
NSN, MFG P/N
6505012437919
NSN
6505-01-243-7919
MFG
NOVO NORDISK INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS INSULIN, ISOPHANE PER MILLILITER
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
RAW MATERIAL SOURCE: PORK PANCREAS
SPECIAL FEATURES: DERIVED BY ENZYMATIC MODIFICATION OF PORK INSULIN
Related Searches:
DURICEF
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP SQUIBB US PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFADROXIL CAPSULES USP 500MG 50S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00087-0784-46
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
NDC00087-0784-46
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
MFG
BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP SQUIBB US PHARMACEUTICAL DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFADROXIL CAPSULES USP 500MG 50S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00172-4058-48
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
NDC00172-4058-48
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFADROXIL CAPSULES USP 500MG 50S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59772-7271-03
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
NDC59772-7271-03
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFADROXIL CAPSULES USP 500MG 50S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC59772-7271-30
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
NDC59772-7271-30
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
MFG
BRISTOL-MYERS CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFADROXIL CAPSULES USP 500MG 50S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
ULTRACEF
CEFADROXIL CAPSULES,USP
NSN, MFG P/N
6505012440211
NSN
6505-01-244-0211
MFG
MEAD JOHNSON & COMPANY DBA MEAD JOHNSON NUTRITIONALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 500.000 MILLIGRAMS CEFADROXIL ACTIVE INGREDIENT
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFADROXIL CAPSULES USP 500MG 50S BT
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00186-0654-01
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012442619
NSN
6505-01-244-2619
NDC00186-0654-01
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012442619
NSN
6505-01-244-2619
MFG
ASTRA PHARMACEUTICALS LP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 50.000 MILLILITERS
PRIMARY CONTAINER TYPE: SYRINGE WITH NEEDLE
SPECIAL FEATURES: 19 GAGE BY 15/16 IN. THINWALL NEEDLE
Related Searches:
470-5899
TERPIN HYDRATE AND CODEINE ELIXIR,USP
NSN, MFG P/N
6505012442620
NSN
6505-01-244-2620
470-5899
TERPIN HYDRATE AND CODEINE ELIXIR,USP
NSN, MFG P/N
6505012442620
NSN
6505-01-244-2620
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CODEINE NITRATE PER MILLILITER AND 17.000 MILLIGRAMS TERPIN HYDRATE PER MILLILITER
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
III THERAPEUTIC EQUIVALENT: HENRY SCHEIN & CO.
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00364-7058-99
TERPIN HYDRATE AND CODEINE ELIXIR,USP
NSN, MFG P/N
6505012442620
NSN
6505-01-244-2620
NDC00364-7058-99
TERPIN HYDRATE AND CODEINE ELIXIR,USP
NSN, MFG P/N
6505012442620
NSN
6505-01-244-2620
MFG
SCHEIN HENRY INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CODEINE NITRATE PER MILLILITER AND 17.000 MILLIGRAMS TERPIN HYDRATE PER MILLILITER
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
III THERAPEUTIC EQUIVALENT: HENRY SCHEIN & CO.
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
KEFLIN
CEPHALOTHIN FOR INJECTION,USP
NSN, MFG P/N
6505012442774
NSN
6505-01-244-2774
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEPHALOTHIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHALOTHIN SODIUM FOR INJECTION USP 2 GM BOTTLE 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20 ML SIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00002-7003-10
CEPHALOTHIN FOR INJECTION,USP
NSN, MFG P/N
6505012442774
NSN
6505-01-244-2774
NDC00002-7003-10
CEPHALOTHIN FOR INJECTION,USP
NSN, MFG P/N
6505012442774
NSN
6505-01-244-2774
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEPHALOTHIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEPHALOTHIN SODIUM FOR INJECTION USP 2 GM BOTTLE 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 GRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 20 ML SIZE VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00409-2308-01
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012444736
NSN
6505-01-244-4736
NDC00409-2308-01
MIDAZOLAM HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505012444736
NSN
6505-01-244-4736
MFG
HOSPIRA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS MIDAZOLAM EQUIVALENT PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MIDAZOLAM HYDROCHLORIDE INJECTION 5MG/ML 1ML VIAL 10S
III SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 10
